Skip to content
Hantavirus.Watcher
Menu
← Back to ledger
DeathPublished Jun 3 · 2026AI-classified · awaiting human verification

Hantavirus, Chile - BEACON

Read original atbeacon.who.int

ChileConfidence 90%41 affectedJun 3, 2026

Chile has reported 41 cases and 14 deaths from Andes hantavirus in the 2026 season, including recent fatal cases among aquaculture divers in Aysén and a pediatric case in Hijuelas.

Source articles

Every claim above is derived from publicly available reporting. Click through to read the original at the publisher.

  • Primary
    Hantavirus, Chile - BEACON

    beacon.who.int · 2026-06-03

    As of May 9, 2026, Chile has reported 41 cases and 14 deaths from Andes hantavirus during the 2026 season, indicating an elevated case fatality rate. Recent cases include two occupational cases among aquaculture divers in Aysén Region, one of whom died, and a fatal pediatric case in Hijuelas, Valparaíso Region.

  • Reference
    Chile reports 41 cases and 14 deaths from hantavirus so far in 2026

    vertexaisearch.cloud.google.com · 2026-06-03

    As of May 9, 2026, Chile's Ministry of Health reported 41 hantavirus cases and 14 deaths for the 2026 season. Cases are concentrated in rural areas with rodent exposure across several regions, including Biobío, Los Lagos (Osorno, Puerto Varas, Puerto Montt), Los Ríos (Corral, Purranque), Araucanía (Temuco), Valparaíso (Hijuelas, Limache), and Aysén. The high case fatality rate of 43% reported earlier in the season has been a concern. Health authorities emphasize preventive measures, especially during warmer months when rodent activity and human outdoor activities increase.

  • Reference
    Hantavirus, Chile - BEACON

    beacon.who.int · 2026-06-03

    Chile has reported an elevated Hantavirus (Andes virus) case fatality rate during the 2026 season, with 41 cases and 14 deaths as of May 9, 2026. This indicates a significant increase in severity compared to previous years. Recent reports include two occupational hantavirus cases among aquaculture divers in the Aysén Region, resulting in one death and one critical condition. Another case was reported in the Los Lagos Region, associated with outdoor activities in Cochamó. Fatal pediatric and adult hantavirus cases have also been reported in the Valparaíso Region, specifically in Hijuelas and

  • Reference
    Chile records 39 cases of hantavirus so far in 2026 and an increase in lethality

    deultimominuto.net · 2026-06-03

    Chile has confirmed 39 hantavirus cases and 13 deaths so far in 2026, resulting in a 33% lethality rate, an increase compared to 2025. Cases are spread across nine of the country's 16 regions, primarily in the central and southern zones. The Andes variant, known for potential human-to-human transmission, is predominant. Most cases occur during the austral summer, often linked to inhalation of viral particles from rodent excreta during outdoor activities.

  • Reference
    Hantavirus, Chile - BEACON

    beacon.who.int · 2026-06-03

    As of May 9, 2026, Chile has reported an elevated hantavirus (Andes virus) case fatality rate for the 2026 season, with 41 cases and 14 deaths. Recent reports include two occupational cases among aquaculture divers in Aysén Region (one death), a sixth case in Los Lagos Region linked to outdoor activities in Cochamó, and fatal pediatric and adult cases in Valparaíso Region (Hijuelas and Limache).

  • Reference
    Chile records 39 cases of hantavirus so far in 2026 and an increase in lethality

    vertexaisearch.cloud.google.com · 2026-06-03

    As of May 6, 2026, Chile has confirmed at least 39 hantavirus cases and 13 deaths this year, resulting in a 33% lethality rate, an increase compared to 2025. Infections have been reported in 9 of the country's 16 regions, primarily in the central and southern zones, including Metropolitana, O'Higgins, Maule, Ñuble, Biobío, La Araucanía, Los Ríos, Los Lagos, and Aysén. The virus, transmitted by the long-tailed mouse, is endemic to Chile, particularly in the humid forests of the south.

Reminder

This report is an aggregated summary of public information for surveillance and awareness purposes only. It is not medical advice. For symptoms, exposure, or clinical decisions, contact a qualified clinician or your local public-health authority.